Where options run out, BRIA-ABC bets on survival in metastatic breast cancer
Metastatic breast cancer trial activity remains high, but GlobalData analysis shows development is still concentrated in Phase I and II studies.
Comment & Opinion
Real-time clinical trials: what it means for procurement strategy
Temperature and air pollution associated with increased risk of type 2 diabetes
Alzheimer’s disease market expected to reach $14.7bn across the 8MM by 2033
MimiVax announces disappointing pivotal Phase IIb trial data for cancer vaccine
How advances in drug discovery are changing the path from research to clinical trials
Parkinson’s disease market expected to reach $7.2bn across the 7MM by 2033
EASD 2026: GLP-1 and SGLT2 treatment lowers mortality in heart failure patients
